Column Group LLC

In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), Column Group LLC reported 3 stock positions worth $88.1 million. Its top holding was Surrozen (SRZN) at 56.5% of the portfolio, followed by Oric Pharmaceuticals (ORIC, 43.5%) and Revolution Medicines (RVMD, 0.0%). Its holdings were unchanged from Q1 2026.

Most Recent 13F
Q2 2026
Location
San Francisco, CA
CIK
0001833486
Portfolio Value
$88.1M (Q2 2026)
SEC Filing
0001193125-26-352333 ↗ filed Aug 14, 2026

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $160.5M Q1 2024 Q2 2024: $71.3M Q2 2024 Q3 2024: $69.6M Q3 2024 Q4 2024: $55.7M Q4 2024 Q1 2025: $44.2M Q1 2025 Q2 2025: $65.7M Q2 2025 Q3 2025: $81.0M Q3 2025 Q4 2025: $82.8M Q4 2025 Q1 2026: $100.7M Q1 2026 Q2 2026: $88.1M $88.1M Q2 2026

Holdings 3 stocks · $88.1M
SRZN Surrozen Inc. 56.46% 1,916,950 $49.7M No change
ORIC Oric Pharmaceuticals Inc. 43.53% 3,540,777 $38.3M No change
RVMD Revolution Medicines Inc. 0.01% 46 $9K No change

Portfolio Sells Q1 2026 → Q2 2026
None this quarter.

Portfolio Buys Q1 2026 → Q2 2026
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$88.1MSRZN, ORIC, RVMD
Q1 2026 3$100.7MSRZN, ORIC, RVMD
Q4 2025 5$82.8MSRZN, ORIC, TNYA, RAPT THERAPEUTICS INC, RVMD
Q3 2025 5$81.0MORIC, SRZN, TNYA, RAPT THERAPEUTICS INC, RVMD
Q2 2025 5$65.7MORIC, SRZN, RAPT THERAPEUTICS INC, TNYA, RVMD
Q1 2025 5$44.2MORIC, SRZN, TNYA, RAPT THERAPEUTICS INC, RVMD
Q4 2024 5$55.7MORIC, TNYA, SRZN, RAPT THERAPEUTICS INC, RVMD
Q3 2024 6$69.6MORIC, TNYA, SRZN, RAPT THERAPEUTICS INC, SGMT
Q2 2024 6$71.3MTNYA, ORIC, SRZN, RAPT THERAPEUTICS INC, SGMT
Q1 2024 7$160.5MTNYA, ORIC, NGM, RAPT THERAPEUTICS INC, SRZN